Literature DB >> 21080027

Emerging topics and new perspectives on HLA-G.

Enrico Fainardi1, Massimiliano Castellazzi, Marina Stignani, Fabio Morandi, Gwenaëlle Sana, Rafael Gonzalez, Vito Pistoia, Olavio Roberto Baricordi, Etienne Sokal, Josè Peña.   

Abstract

Following the Fifth International Conference on non-classical HLA-G antigens (HLA-G), held in Paris in July 2009, we selected some topics which focus on emerging aspects in the setting of HLA-G functions. In particular, HLA-G molecules could play a role in: (1) various inflammatory disorders, such as multiple sclerosis, intracerebral hemorrhage, gastrointestinal, skin and rheumatic diseases, and asthma, where they may act as immunoregulatory factors; (2) the mechanisms to escape immune surveillance utilized by several viruses, such as human cytomegalovirus, herpes simplex virus type 1, rabies virus, hepatitis C virus, influenza virus type A and human immunodeficiency virus 1 (HIV-1); and (3) cytokine/chemokine network and stem cell transplantation, since they seem to modulate cell migration by the downregulation of chemokine receptor expression and mesenchymal stem cell activity blocking of effector cell functions and the generation of regulatory T cells. However, the immunomodulatory circuits mediated by HLA-G proteins still remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080027     DOI: 10.1007/s00018-010-0584-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  148 in total

1.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

2.  Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients.

Authors:  A Rivero; J M Lozano; R González; G García-Jurado; A Camacho; J Torres-Cisneros; J Peña
Journal:  Hum Immunol       Date:  2006-11-16       Impact factor: 2.850

Review 3.  Mesenchymal stem cells: a new strategy for immunosuppression?

Authors:  Antonio Uccelli; Vito Pistoia; Lorenzo Moretta
Journal:  Trends Immunol       Date:  2007-04-02       Impact factor: 16.687

Review 4.  The role of human leukocyte antigen E and G in HIV infection.

Authors:  Piyush Tripathi; Suraksha Agrawal
Journal:  AIDS       Date:  2007-07-11       Impact factor: 4.177

5.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

6.  HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.

Authors:  R Rizzo; T V F Hviid; M Govoni; M Padovan; M Rubini; L Melchiorri; M Stignani; S Carturan; M T Grappa; M Fotinidi; S Ferretti; A Voss; H Laustrup; P Junker; F Trotta; O R Baricordi
Journal:  Tissue Antigens       Date:  2008-03-29

7.  Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Authors:  Fabio Morandi; Lizzia Raffaghello; Giovanna Bianchi; Francesca Meloni; Annalisa Salis; Enrico Millo; Soldano Ferrone; Vincenzo Barnaba; Vito Pistoia
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

8.  Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.

Authors:  Pilar Delgado; Eloy Cuadrado; Anna Rosell; José Alvarez-Sabín; Arantxa Ortega-Aznar; Mar Hernández-Guillamón; Anna Penalba; Carlos A Molina; Joan Montaner
Journal:  Stroke       Date:  2008-04-10       Impact factor: 7.914

9.  Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

Authors:  David Campard; Philippe A Lysy; Mustapha Najimi; Etienne Marc Sokal
Journal:  Gastroenterology       Date:  2007-12-23       Impact factor: 22.682

10.  HLA-G expression is up-regulated by progesterone in mesenchymal stem cells.

Authors:  Ekaterina Ivanova-Todorova; Milena Mourdjeva; Dobroslav Kyurkchiev; Ivan Bochev; Elena Stoyanova; Rumen Dimitrov; Tanya Timeva; Maria Yunakova; Dimitar Bukarev; Atanas Shterev; Petar Tivchev; Stanimir Kyurkchiev
Journal:  Am J Reprod Immunol       Date:  2009-07       Impact factor: 3.886

View more
  24 in total

1.  Suppression of natural killer cell cytotoxicity in postpartum women: time course and potential mechanisms.

Authors:  Maureen W Groer; Nagwa El-Badri; Julie Djeu; S Nicole Williams; Bradley Kane; Karoly Szekeres
Journal:  Biol Res Nurs       Date:  2013-08-15       Impact factor: 2.522

2.  Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.

Authors:  Fabio Morandi; Consuelo Venturi; Roberta Rizzo; Massimiliano Castellazzi; Eleonora Baldi; Maria Luisa Caniatti; Maria Rosaria Tola; Enrico Granieri; Enrico Fainardi; Antonio Uccelli; Vito Pistoia
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-28       Impact factor: 4.147

3.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

Review 4.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

5.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

Review 6.  The progress of early growth response factor 1 and leukemia.

Authors:  Jing Tian; Ziwei Li; Yang Han; Tao Jiang; Xiaoming Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-05

7.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

8.  Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

Authors:  Roberta Rizzo; Alessandro Trentini; Daria Bortolotti; Maria C Manfrinato; Antonella Rotola; Massimiliano Castellazzi; Loredana Melchiorri; Dario Di Luca; Franco Dallocchio; Enrico Fainardi; Tiziana Bellini
Journal:  Mol Cell Biochem       Date:  2013-06-05       Impact factor: 3.396

9.  High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy.

Authors:  Ibrahim Sadissou; Tania d'Almeida; Gilles Cottrell; Adrian Luty; Irène Krawice-Radanne; Achille Massougbodji; Philippe Moreau; Kabirou Moutairou; André Garcia; Benoit Favier; Nathalie Rouas-Freiss; David Courtin
Journal:  Malar J       Date:  2014-08-12       Impact factor: 2.979

10.  Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection.

Authors:  Chun Li; Ilona Toth; Julian Schulze Zur Wiesch; Florencia Pereyra; Jennifer Rychert; Eric S Rosenberg; Jan van Lunzen; Mathias Lichterfeld; Xu G Yu
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.